Lingjing Xue

3.3k total citations · 1 hit paper
53 papers, 2.8k citations indexed

About

Lingjing Xue is a scholar working on Molecular Biology, Biomedical Engineering and Immunology. According to data from OpenAlex, Lingjing Xue has authored 53 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 19 papers in Biomedical Engineering and 17 papers in Immunology. Recurrent topics in Lingjing Xue's work include Nanoplatforms for cancer theranostics (18 papers), RNA Interference and Gene Delivery (14 papers) and Nanoparticle-Based Drug Delivery (12 papers). Lingjing Xue is often cited by papers focused on Nanoplatforms for cancer theranostics (18 papers), RNA Interference and Gene Delivery (14 papers) and Nanoparticle-Based Drug Delivery (12 papers). Lingjing Xue collaborates with scholars based in China, United States and Australia. Lingjing Xue's co-authors include Can Zhang, Ran Mo, Caoyun Ju, Hongbin Sun, Qineng Ping, Jingwei Xue, Zhigui Su, Zekai Zhao, Lingyi Kong and Yajing Wen and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Lingjing Xue

52 papers receiving 2.8k citations

Hit Papers

Neutrophil-mediated anticancer drug delivery for suppress... 2017 2026 2020 2023 2017 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence
    2017 813 citations Jingwei Xue, Zekai Zhao et al. profile →

Peers

Lingjing Xue
Nasha Qiu China
Man Kyu Shim South Korea
Chuan Hu China
Ying Piao China
Haiqiang Cao China
Cong‐Fei Xu China
Cao Xie China
Jiajia Xiang China
Nasha Qiu China
Lingjing Xue
Citations per year, relative to Lingjing Xue Lingjing Xue (= 1×) peers Nasha Qiu

Countries citing papers authored by Lingjing Xue

Since Specialization
Citations

This map shows the geographic impact of Lingjing Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingjing Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingjing Xue more than expected).

Fields of papers citing papers by Lingjing Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingjing Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingjing Xue. The network helps show where Lingjing Xue may publish in the future.

Co-authorship network of co-authors of Lingjing Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Lingjing Xue. A scholar is included among the top collaborators of Lingjing Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingjing Xue. Lingjing Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yijun, Yongbin Wang, Rui Yan, et al.. (2025). Dual metabolic-inflammation modulation in MicroRNA@neutrophil-derived microvesicles achieve robust osteoarthritis therapy. Acta Pharmaceutica Sinica B. 16(1). 423–443.
2.
Zhang, Luping, Jiaqi Chen, Tong Wu, et al.. (2023). New-generation cytopharmaceuticals with powerfully boosted extravasation for enhanced cancer therapy. Journal of Controlled Release. 359. 116–131. 3 indexed citations
3.
Yin, Shi, et al.. (2023). An elastase-inhibiting, plaque-targeting and neutrophil-hitchhiking liposome against atherosclerosis. Acta Biomaterialia. 173. 470–481. 24 indexed citations
4.
Wang, Cong, Yijun Chen, Lingjing Xue, et al.. (2022). Targeted downregulation of HIF-1α for restraining circulating tumor microemboli mediated metastasis. Journal of Controlled Release. 343. 457–468. 14 indexed citations
5.
Li, Kaiming, Yue Chen, Sijia Chen, et al.. (2022). Real-time detection of T cell activation by visualizing TCR nanoclusters with a cholesterol derived aggregation-induced emission probe. European Journal of Medicinal Chemistry. 247. 115073–115073. 4 indexed citations
6.
Li, Kaiming, et al.. (2022). Reprogrammed siTNFα/neutrophil cytopharmaceuticals targeting inflamed joints for rheumatoid arthritis therapy. Acta Pharmaceutica Sinica B. 13(2). 787–803. 20 indexed citations
7.
Yu, Tao, Ding Qu, Lingjing Xue, et al.. (2021). Modular synthesis of amphiphilic chitosan derivatives based on copper-free click reaction for drug delivery. International Journal of Pharmaceutics. 605. 120798–120798. 13 indexed citations
8.
Hao, Meixi, Siyuan Hou, Weishuo Li, et al.. (2020). Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy. Science Translational Medicine. 12(571). 142 indexed citations
9.
Wu, Yue, Yong Zhang, Lili Dai, et al.. (2019). An apoptotic body-biomimic liposome in situ upregulates anti-inflammatory macrophages for stabilization of atherosclerotic plaques. Journal of Controlled Release. 316. 236–249. 69 indexed citations
10.
Zhou, Anwei, Qianqian Wang, Lingjing Xue, et al.. (2019). Co-delivery of TRAIL and siHSP70 using hierarchically modular assembly formulations achieves enhanced TRAIL-resistant cancer therapy. Journal of Controlled Release. 304. 111–124. 24 indexed citations
11.
Wang, Cong, Bin Wang, Siyuan Hou, et al.. (2018). Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer. European Journal of Medicinal Chemistry. 163. 787–803. 10 indexed citations
12.
Qu, Guowei, Siyuan Hou, Ding Qu, et al.. (2018). Self-assembled micelles based on N-octyl-N’-phthalyl-O-phosphoryl chitosan derivative as an effective oral carrier of paclitaxel. Carbohydrate Polymers. 207. 428–439. 39 indexed citations
13.
Chen, Xinyan, Chunming Tang, Qiong Sun, et al.. (2017). Co-delivery of paclitaxel and anti-survivin siRNA via redox-sensitive oligopeptide liposomes for the synergistic treatment of breast cancer and metastasis. International Journal of Pharmaceutics. 529(1-2). 102–115. 74 indexed citations
14.
Wang, Tingfang, Xiaofei Liu, Meixi Hao, et al.. (2016). Design, synthesis and evaluation of pyrrolo[2,3-d]pyrimidine-phenylamide hybrids as potent Janus kinase 2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(12). 2936–2941. 11 indexed citations
15.
Yin, Siyuan, Chunming Tang, Bin Wang, et al.. (2016). Design, synthesis and biological evaluation of novel EGFR/HER2 dual inhibitors bearing a oxazolo[4,5-g]quinazolin-2(1H)-one scaffold. European Journal of Medicinal Chemistry. 120. 26–36. 41 indexed citations
16.
He, Yongju, Zhigui Su, Lingjing Xue, Hui Xu, & Can Zhang. (2016). Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy. Journal of Controlled Release. 229. 80–92. 108 indexed citations
17.
Zhang, Nan, Xue Zhang, Ding Qu, et al.. (2015). Nanocomposite hydrogel incorporating gold nanorods and paclitaxel-loaded chitosan micelles for combination photothermal–chemotherapy. International Journal of Pharmaceutics. 497(1-2). 210–221. 61 indexed citations
18.
Yin, Siyuan, et al.. (2015). Design, synthesis and biological activities of novel oxazolo[4,5- g ]quinazolin-2(1H)-one derivatives as EGFR inhibitors. European Journal of Medicinal Chemistry. 101. 462–475. 32 indexed citations
19.
Hao, Meixi, et al.. (2015). Novel nonsecosteroidal VDR ligands with phenyl-pyrrolyl pentane skeleton for cancer therapy. European Journal of Medicinal Chemistry. 107. 48–62. 8 indexed citations
20.
Ju, Caoyun, Ran Mo, Jingwei Xue, et al.. (2014). Sequential Intra‐Intercellular Nanoparticle Delivery System for Deep Tumor Penetration. Angewandte Chemie International Edition. 53(24). 6253–6258. 205 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nasha Qiu Breakdown of academic impact, for papers by Man Kyu Shim Breakdown of academic impact, for papers by Chuan Hu Breakdown of academic impact, for papers by Ying Piao Breakdown of academic impact, for papers by Haiqiang Cao Breakdown of academic impact, for papers by Cong‐Fei Xu Breakdown of academic impact, for papers by Cao Xie Breakdown of academic impact, for papers by Jiajia Xiang
Rankless by CCL
2026